The present invention is directed to fused tetrazoles of formula (IA) which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
-
Page/Page column 62-63
(2019/12/04)
BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS
The present invention provides compounds of Formula (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
-
Paragraph 0395; 0396
(2014/09/29)
More Articles about upstream products of 888721-86-6